Advances in our understanding of the structure and molecular biology of the T lymphocyte antigen-receptor have now made it feasible to study human autoimmune diseases using new approaches. One such approach involves cloning of T cells from sites of autoimmune pathology followed by identification of putative disease-related T cell oligoclonality at the level of the T cell receptor gene rearrangements. We have now tested the feasibility of this approach in an animal model of autoimmunity, murine experimental allergic encephalomyelitis (EAE). Spinal cord-derived, self (murine) myelin basic protein (MBP)-reactive T cell lines and sublines were analyzed at the level of their receptor beta chain rearrangements using Southern blots. We now report that the MBP-reactive T cell lines and sublines derived from the spinal cords of four of five SJL/J mice with EAE share a 14.5-kb rearranged T cell receptor beta 1 band on Southern blots. A spinal cord-derived T cell line that was reactive to purified protein derivative of tuberculin (PPD), several lymph node-derived ovalbumin-and PPD-reactive T cell lines, as well as one MBP-reactive spinal cord-derived T cell line did not share this 14.5-kb rearranged beta 1 band. These results suggest that analysis of the antigen receptors used by T cells cloned from sites of inflammation may be a useful initial approach for identifying pathogenetically relevant T cells in the study of certain human autoimmune diseases.
Introduction
Recent advances in the molecular biology ofthe T cell receptor are now allowing for novel approaches to the investigation of heretofore enigmatic diseases. One such group of diseases are those which are termed "autoimmune diseases." In certain of these autoimmune diseases such as RA and multiple sclerosis (MS)', T cells appear to play an important part in the pathophysiology. Despite numerous studies of the peripheral blood Address all correspondence to Dr. Steven J. Padula, Division of Rheumatic Diseases, University of Connecticut School of Medicine, Farmington, CT 06032. Receivedfor publication 21 May 1987 and in revisedform 22 October 1987.
1. Abbreviations used in this paper: EAE, experimental allergic encephalomyelitis; LN, lymph node; MBP, myelin basic protein; MS, multiple sclerosis; OVA, ovalbumin; PB, peripheral blood; PPD, purified protein derivative of tuberculin; SC, spinal cord.
T cells in patients with RA or MS, the etiology ofthese diseases remains unknown. Recent investigations have focused on T cells derived from sites-of-pathology (i.e., the synovium in RA and the central nervous system in MS), and T cell lines and clones have been derived from these sites-of-pathology (1, 2) . However, despite the use of T cell cloning technology in these autoimmune diseases, relevant issues such as the antigen(s) of etiologic significance in such diseases remain unresolved. The lack of knowledge of disease-relevant antigens has, in turn, made the utilization of T cell cloning technology less than optimal. We have recently developed a strategy to deal with this problem using anti-T3 antibody in lieu of antigen (3, 4) . With the development of DNA probes for the various gene segments of the T cell receptor a new approach for studying "autoimmune" diseases such as MS and RA has become feasible. The hypothesis underlying this approach is that ifthere are disease-specific antigens localized in the sites of pathology in these diseases, and if such antigens are eliciting T cell-mediated inflammatory responses, then it may be possible to identify inflammatory site, disease-relevant populations of T cells even without knowledge of the "disease-specific antigens." Theoretically, such populations of inflammatory site, "disease-antigen-reactive" T cells could be identified through characterization ofthe distinct clonal or oligoclonal patterns of rearranged genes encoding for their antigen receptors. Therapeutic efforts could then be focused on the elimination or inhibition of such possibly pathogenetic T cell clones.
Although great progress has been made in our understanding of the biochemical and genetic structure of the T cell receptor, relatively little is known about the structure-function relationship between antigen, MHC determinants, and the T cell receptor (5) (6) (7) . In addition, as yet, there has been no characterization ofthe antigen receptors used by T cells responding in vivo to a known antigen at a site of inflammation.
Experimental allergic encephalomyelitis (EAE) is considered a prototypic animal model of a T cell-mediated autoimmune disease (8) . In this model, sensitization of an animal with myelin basic protein (MBP) leads to a clinical and histological disease with many similarities to MS. We have recently shown that T cell lines can be derived directly from the central nervous system (the spinal cords) of mice with EAE (9) . We have further demonstrated that, although such mice were sensitized to porcine MBP, the spinal cord (SC)-derived T cells were "autoreactive" in that they all also proliferated to murine (self) MBP (9) . In contrast, we found that T cell lines derived from the peripheral blood (PB) ofsuch mice were responsive to porcine MBP but were not (with one exception) responsive to murine (self) MBP (9) . Thus, EAE, an autoimmune disease with a compartmentalized site-of-pathology and a well defined "relevant antigen," represents an ideal animal model for testing site-of-pathology T cell cloning followed by receptor gene analysis as an approach to studying human autoimmune dis-eases. We now report the identification ofa T cell receptor beta 1 gene rearrangement used by the SC-derived T cell lines from four of five mice with EAE.
Methods
Induction ofEAE. EAE was induced in male SJL/J mice, aged 4-8 wk (obtained from the National Institutes of Health). The mice used for the derivation of the SC T cell lines received sublethal (450 rad) irradiation from a Cs 137 source 2 wk before sensitization with MBP. Sensitization to MBP was induced by hind foot pad injections totaling 0.1 ml and containing 100-250 ,ug (total per mouse) of porcine MBP (Calbiochem-Behring Corp., La Jolla, CA) emulsified in an equal volume of CFA, which was supplemented with 6 Aig/ml of desiccated Mycobacterium tuberculosis H37RA (Difco Laboratories, Inc., Detroit, MI). This sensitization was followed at 24 and 72 h by an intravenous injection of 2.2 X 100' formalin-fixed, washed Bordetella pertussis organisms (Michigan Department of Health). Sensitized mice were killed at the height of their clinical signs, [13] [14] [15] [16] Cell culture. T cell lines were derived from the SCs of mnice with EAE as previously described (9) . Briefly, after the mice were killed, their vertebral columns and a small amount of perivertebral tissue were removed under sterile conditions. Each SC was then removed from the vertebral column by injecting 5-10 ml ofair into the vertebral canal with an 18-gauge needle and a 10-ml syringe. Each SC was put into a single cell suspension through a nylon mesh screen. The SC suspension was cultured in three to six wells of a 24-well multiwell plate (Costar Corp., Cambridge, MA). These cultures were established in complete media: RPMI 1640 (Biofluids, Inc., Bethesda, MD) with 100 U/ml penicillin, 100 Mg/ml streptomycin, 10 Mg/ml gentamycin, 10% FCS, and 5 X I0-' M 2-mercaptoethanol. Added to these cultures at their initiation were 10 sg/ml porcine MBP (a generous gift of Eli Lilly Co., Indianapolis, IN), 10-15% IL-2, and 1-4 X 106 irradiated (1,300 rad) SJL/J splenocytes per well. Our source of IL-2 was purified rat IL-2 (Collaborative Research, Inc., Lexington, MA) and crude supernatants of Con A-stimulated rat splenocytes to which alpha-methylmannopyranoside had been added to inhibit Con A activity. These cultures were fed twice per week with 10-15% IL-2. Fresh irradiated SJL/J splenocytes and porcine MBP were added biweekly. As T cells became morphologically apparent in the cultures, the cultures were expanded into additional wells as needed. For SC-derived T cell lines that were reactive to the purified protein derivative of tuberculin (PPD), similar protocols were used except that PPD was used instead of porcine MBP in the in vitro propagation of the lines. PB-derived lines were generated as above, with the only difference being the use of 10-50 Ml of heparinized whole blood rather than SC tissue to initiate the cultures. As above, such cultures were also initiated and fed by using porcine MBP, irradiated SJL/J splenocytes, and 10-15% IL-2. The 15 Mig of di-gested DNA was separated on 0.8% agarose gels in Tris-acetate buffer and transferred to nitrocellulose paper according to the method of Southern (14). The filters were hybridized in 0.60 M NaCI/0.060 M sodium citrate (pH 7.0), 40% formamide, 10% dextran sulfate, 0.0 16% Ficoll, 0.016% BSA, 0.016% polyvinylpyrrolidone, 7 mM Tris-HCI (pH 7.5), 100 Ag/ml sonicated salmon sperm DNA, and 106 cpm/ml radioactive probe. Hybridization was performed at 420C for 12-16 h. Filters were washed at room temperature in 0.30 M NaCl/0.030 M sodium citrate (pH 7.0), 0.1% SDS for 20 min, which was repeated once, and then they were washed at high stringency in 0.03 M NaCl/0.003 M sodium citrate (pH 7.0), 0.1% SDS at 650C for 15 min two times. Filters were then air dried and exposed for 16-24 h to Kodak XAR-5 film at -70'C using intensifying screens.
Probes. The Jbeta 1 and Jbeta 2 region probes were isolated from two genomic clones kindly provided by Dr. Stephen Hedrick, University of California, San Diego, CA (5). The Jbeta 1 probe is a 1.3-kb fragment extending from the Sph I site 5 to Jbeta 1.4, to the Sac I site 3' to Jbeta 1.7. The Jbeta 2 probe is a 1.2-kb Eco RI-Cla I fragment spanning the entire Jbeta 2 region. These Jbeta probes will detect all beta chain rearrangements when DNA is digested with Hind III or Eco Rl (5, 6) . The probes were radiolabeled to a specific activity of I09 cpm/jug by using random oligonucleotide primers and the large fragment of DNA polymerase I with [alpha-32P]dCTP after the method of Feinberg and Vogelstein (15).
Results
Generation of T cell lines and clones. As previously described, mice 2-6 were all suffering from grade 3 clinical EAE with bilateral fore-and hindlimb paralysis when killed (9) . All mice were killed between days 13 and 16 after sensitization with CFA and MBP. Mouse 9 had no clinical signs of EAE after MBP sensitization, but had grade 2 changes of histological EAE. The SC cultures of mice 2-6 were propagated with IL-2, syngeneic irradiated splenocytes (as antigen presenting cells), and porcine MBP as previously described (9) . The SC cultures of mouse 9 were propagated similarly, except that the PPD was used instead of porcine MBP.
The T cells that grew from the SC cultures of mice 2-6 were termed lines SC-2, SC-3, SC-4, etc. The T cell line generated from the SC of mouse 9 was termed SC-9-PPD. Thus, each T cell line represents a heterogeneous T cell population grown from the SC of an individual mouse. These lines had been propagated in culture (with intermittent periods of cryopreservation) in our laboratory over a period of -6 mo when studied. In addition, SC-2 and SC-4 were subcultured at 10 cells/well, and SC-5 was subcultured at 1 cell/well, and the resulting sublines (SC-2. 10, SC-2.17, SC-4. 1, SC-4.7, and SC-5.0.9.) had also been maintained for I 6 mo when studied. In addition, one of these sublines, SC Proliferative response of T cell lines and clones. As seen in Table I , SC-2 through SC-6, their sublines, and clone SC-2. 17.17.11 all respond to both porcine MBP (the immunogen) and to self (murine) MBP. We have previously demonstrated that PB-derived lines from these mice, although propagated in vitro in a fashion similar to the SC-derived lines, often respond to porcine MBP, but do not usually respond to murine MBP (9) . The only PB-derived line that initially showed any reactivity to self (murine) MBP was PB-5 (9), though this line has become nonresponsive to murine MBP over time in culture (Table I) . As can be seen in Table I , SC-2 through SC-6 and their sublines do not respond to PPD. Line JHL also responds to both porcine MBP and to murine MBP, but not to PPD. In contrast and as expected, SC-9-PPD, propagated with PPD rather than MBP, responds to PPD but not to either porcine or murine MBP.
We have now assayed the proliferative responses of the SC-derived lines, sublines, and clones from mice 2-6, the PBderived line from mouse 5, and line JHL to the pepsin-digested fragments ofguinea pig MBP. As can be seen in Table II , while PB-5 and all of the SC-derived lines and sublines respond to (the intact) guinea pig MBP, all except SC-4 and SC-5 fail to respond to any of the three pepsin-digested fragments of the guinea pig MBP molecule. SC-4 and SC-5 (though not their sublines) demonstrate a very small response to fragment 2, and SC-4 also demonstrates a very small response to fragment 1. In general, however, PB-5 and the SC-derived lines and sublines from mice 2-6 all appear to respond primarily to a tertiary conformational determinant on the guinea pig MBP molecule or to an overlap determinant lost in producing the MBP fragments. A similar specificity for a tertiary conformational or overlap epitope of the MBP-molecule has been previously described among LN-derived T cell clones derived from SJL/J mice sensitized to MBP (16 (Fig. 1, lanes  a-g; Fig. 2, lane d) , and SC-5, SC-5.0.9, and PB-5 (Fig. 3, lanes  d-f) Fig. 1, lane i; Fig. 2, lane b; and Fig. 3 , lane a.) The LN-derived line JHL also demonstrates this rearranged band (this band appears only very faintly in Fig. 3, lane  b) . As seen in Fig. 1 , lane h, line SC-9-PPD demonstrates no bands with the Jbeta 1 probe which suggests that both Jbeta I gene segment homologues have been deleted. SC-3, SC-4 and its sublines (Fig. 1, lanes a and e-g ), and SC-5.0.9 (Fig. 3 , lane f) demonstrate deletion ofthe other Jbeta 1 allele. SC-2 and its sublines, including the clone SC-2. 17.17.1 1, reveal a second beta 1 band of -13 kb (Fig. 1, lanes b-d and Fig. 2, lane d) . In addition, SC-5 also demonstrates a second beta 1 rearranged band at -8.8 kb (Fig. 3, lane d) . This band (8.8 kb) is also seen in PB-5 in addition to the 14.5-kb band and a beta 1 germ-line band (Fig. 3, lane e) . In contrast, SC-6 does not reveal the 14.5-kb band shared by all the other lines studied (Fig. 3, lane c) .
As seen in Fig. 4 , lanes a and e-g, use of the Jbeta 2 probe and Hind III digestion reveals a germ-line band for SC-3 and (Fig. 4, lanes a-d, f and g,) , whereas SC-3 has a rearranged band at a slightly faster mobility (Fig. 4 , lane e). SC-2 and its sublines, including the clone SC-2. 17.17.1 1, have a second Jbeta 2 Hind III rearrangement at 3.9 kb (Fig. 4 , lanes b-d and Fig. 5, lane d) . PB-5 demonstrates several beta 2 rearrangements (Fig. 6 , lane e), one of which is seen in SC-5 (Fig. 6, lane d) , and another of which is seen in SC-5.0.9 (Fig.  6, lane f) . In addition, SC-5, PB-5, and SC-5.0.9 all demonstrate a Jbeta 2 Hind III germ-line band (Fig. 6, lanes d-f) . It is noteworthy that, in addition, PB-5 has one rearranged band of 4.9 kb (Fig. 6 , lane e) that is seen in neither SC-5 nor SC-5.0.9 (Fig. 6, lanes d and f) . SC-6 demonstrates a germ-line band and a rearranged Jbeta 2 Hind III band (Fig. 6, lane c) . One possible interpretation of these restriction bands is that for SC-3, SC-4, its sublines, and SC-5.0.9, one chromosome (of the predominant clones within these lines) has a beta 1 rearrangement (the shared 14.5-kb fragment), while the Jbeta 2 gene segment of that chromosome is in the germ-line configuration. In this interpretation, the other chromosome has its Jbeta 1 segment deleted with a rearrangement into the Jbeta 2 region. SC-3, SC-4, their sublines, and SC-5.0.9 apparently demonstrate different rearrangements of this second chromosome. SC-2 uses the same 14.5-kb beta 1 rearrangement as the other lines but has a rearranged beta 2 band on the same chromosome. The other chromosome appears to have both Jbeta 1 and Jbeta 2 gene segment rearrangements. The simultaneous appearance of both beta 1 and beta 2 rearrange-6.5 Figure 5 . ments on the same chromosome may be explained by nonproductive Dbeta 2-Jbeta 2 rearrangements (17) . SC-5 also demonstrates two beta 1 rearrangements but appears to have one beta 2 rearrangement and a germ-line band. Given this pattern, a putative chromosomal configuration for SC-5 may involve the 14.5-kb beta 1 band together with the germ-line beta 2, or the 14.5-kb beta 1 band with a beta 2 nonproductive rearranged band. SC-6, on the other hand, has a beta 1 rearrangement (not to 14.5 kb) with a germ-line configuration of the beta 2 on one chromosome, and a deleted beta 1 with a rearranged beta 2 on the other chromosome. For all ofthe lines these chromosomal configurations can only be conjectural at this point.
SC-2, SC-4, and their sublines appear to share a rearranged beta 2 band of 4.7 kb. This band, which travels slightly faster than the germ-line band, may represent a Dbeta 2-Jbeta 2 nonproductive rearrangement. No other shared rearranged band was seen among all of the SC-derived lines, including SC-9-PPD. Eco R1, which also allows detection of all rearrangements with the Jbeta probes, gave similar results on Southern blot analysis as those shown for Hind III (Fig. 2 1.24, did not demonstrate the 14.5-kb band when hybridized with the Jbeta 1 probe. DNA from a PPD-reactive, LN-derived line, PPD 1.24, did not hybridize to the Jbeta 1 probe, which suggests rearrangement to Jbeta 2 on both chromosomes with deletion of both Jbeta 1 gene segments (data not shown).
In light of the same general antigen reactivity of all of the SC-lines and the shared 14.5-kb beta 1 band of four of five of these lines, it seems likely that, with two possible exceptions, the T cell receptor beta chain ofthe predominant clone in each population is encoded by this 14.5-kb beta 1 rearrangement. The two exceptions are SC-6, which is reactive to murine MBP, though it does not demonstrate the shared 14.5-kb beta 1 rearrangement, and PB-5, which has lost its murine MBP reactivity, yet still demonstrates the shared 14.5-kb beta 1 It is important to note that the 14.5-kb beta 1 rearrangement shared among SC-2, -3, -4, and -5 is not seen in either SC-9-PPD or SC-6. The latter two lines were also derived from the SCs of SJL/J mice with EAE, thus demonstrating that the shared rearrangements are not related to the methods by which T cell lines and clones were generated from the SCs. Furthermore, the Southern blot of SC-6 as well as the phenotypic heterogeneity of proliferative responses (e.g., the JHL fragment responses and the lack of a murine-MBP response among most of our PB-derived lines [9] ), demonstrate that the shared rearrangements among SC-2, -3, -4, and -5 are not simply a result of in vitro selection by our methods ofpropagation. It is also noteworthy that PB-5 demonstrated rearrangements (specifically, beta 2 rearrangements) that were not seen with SC-5, though both were derived from the same mouse, at the same time, and were propagated similarly. This finding of T cell receptor beta chain rearrangements within the PB-5 line that were not demonstrated in the blots of SC-5 suggest that the cells derived from the cords have at least a quantitative composition different from those in the PB despite the use of similar in vitro propagation protocols. That this difference may in fact be quantitative rather than qualitative is suggested by the finding that SC-5.0.9, a 1-cell/well subculture of SC-5, demonstrates a beta 2 rearrangement that is different from the one seen in SC-5, but similar to one of those seen in PB-5. Thus, while there are populations present in SC-5 that may not have been seen on these Southern blots and may be similar to those present in PB-5, the clonal compositions of the SC and PB populations derived from the same mouse with EAE differ at least quantitatively. Furthermore, it should again be noted that murine MBP responses were not usually found among our PB-derived lines and that PB-5 was studied because it was the only PB line that demonstrated even a small murine MBP response (9) .
The finding of a common beta chain gene rearrangement used by long-term, IL-2-dependent, MBP-reactive lines derived from the SCs of four of five different mice with EAE suggests that this approach may have applicability as an initial approach in the study of certain human autoimmune diseases. Thus, theoretically, it would have been possible to identify and isolate the four SC-derived lines that possess a common beta chain rearrangement and to distinguish these lines from the SC-derived PPD-specific line, even in the absence of knowing the antigen specificities of the lines. However, it should be noted that a number of significant differences exist between applying this approach to the study of human autoimmune diseases and the study of EAE described in this paper. Such differences include (a) the central nervous system-derived lines in this study were generated during many weeks of in vitro propagation in the presence of the known autoantigen, MBP, and therefore in vitro selection for MBP-responsive populations (though not necessarily for murine MBP-responsive populations) has occurred; in the human disease the relevant antigens are unknown; however, we have previously demonstrated that using anti-T3 antibodies in lieu of relevant antigens does maintain the antigen reactivities of long-term propagated lines (3, 4) ; (b) SJL mice have a 50% decrease in the number of beta variable region gene segments (18) and thus the likelihood of finding a common rearrangement may be increased in this experimental model; however, the heterogeneity of T cell receptors used in the SJL/J murine MBP response does not appear to be extremely limited. Phenotypic heterogeneity of this response is suggested both by the fragment response of line JHL and by the variation in MBP fragment responses seen among LN-derived T cell clones reported by others (16) . In addition, genotypic heterogeneity of the murine MBP response is suggested by our finding of a nonshared rearrangement used by line SC-6. Furthermore, we have shown that SJL/J LN-derived T cell lines reactive to antigens other than MBP do not demonstrate the 14.5-kb rearrangement for their T cell receptor beta chain genes; (c) all of the T cell lines studied were derived from the inflammatory site at approximately the same time point in the inflammatory process (this may be difficult to accomplish in the human studies); and (d) the present experimental system involves mice that are syngeneic and thus the T cell lines and clones recognize MBP in the context of the same MHC determinants. However, in the human studies this may also be the case in that diseases such as MS and RA are known to be associated with increased frequencies of certain DR determinants (19, 20) . While our model involves the optimal conditions under which this approach should work, the present results nevertheless suggest that a similar analysis of T cell receptor rearrangements could be of significant utility in allowing for the initial identification of those site-of-inflammation T cells most likely to be relevant to the initiation and/or propagation of human diseases such as MS or RA.
Similarities in beta chain rearrangements using Southern blot analysis do not define similarities of the entire T cell receptor. Hedrick and Matis and their colleagues have evaluated the T cell receptors used by T cell clones specific for related but clearly different antigens (5, 6) . In their studies they found that their clones used a limited number of variable region genes for both the alpha and beta chains. They concluded that specific antigen/MHC-restricted reactivity is encoded by a combination of the alpha and beta chains and could not be assigned to a specific region or chain of the T cell receptor. However, they did find that variation of the beta chain correlated with changes in fine antigen specificity and that alloreactivity was associated with the use of a particular alpha chain J region gene. It is clear that our results can only constitute a first approximation of the T cell receptors being used by SC-derived T cells in EAE. The next phase of our studies, which involves the more precise definition of the alpha and beta chains of these lines and clones by cDNA sequencing, is presently ongoing. However, the purpose of the present study was to determine the feasibility of using beta chain Southern blot analysis as the initial screen for site-of-inflammation T cell oligoclonality. The present results indeed suggest that T cell receptor-beta chain analysis of site-of-inflammation-derived T cell clones may be useful as the initial approach for isolating (for further in-depth study) the pathogenetically relevant T cells in certain human autoimmune diseases. We are presently using this approach to characterize the T cell receptor-beta chain gene rearrangements used by synovial-derived T cell clones obtained from patients with RA, and the receptor-beta chain gene rearrangements used by cerebrospinal fluid-derived T cell clones obtained from patients with MS.
